Edition:
United States

Guizhou Yibai Pharmaceutical Co Ltd (600594.SS)

600594.SS on Shanghai Stock Exchange

11.42CNY
15 Dec 2017
Change (% chg)

¥-0.07 (-0.61%)
Prev Close
¥11.49
Open
¥11.52
Day's High
¥11.59
Day's Low
¥11.40
Volume
6,810,515
Avg. Vol
11,776,507
52-wk High
¥20.30
52-wk Low
¥10.91

Chart for

About

GUIZHOU YIBAI PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the production and distribution of pharmaceuticals. The Company provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules and tablets, among others. The company's products are... (more)

Overall

Beta: 0.93
Market Cap(Mil.): ¥9,099.25
Shares Outstanding(Mil.): 791.93
Dividend: 0.06
Yield (%): 0.52

Financials

  Industry Sector
P/E (TTM): -- 32.50 16.04
EPS (TTM): -- -- --
ROI: -- 15.11 35.70
ROE: -- 16.59 15.40

BRIEF-Guizhou Yibai Pharma plans to buy back 200 mln yuan worth of shares

* SAYS IT PLANS TO BUY BACK 200 MILLION YUAN ($30.23 million)WORTH OF COMPANY SHARES AT NO HIGHER THAN 13.0 YUAN PER SHARE WITHIN SIX MONTHS

Nov 30 2017

BRIEF-Guizhou Yibai Pharmaceutical issues 2017 first tranche corporate bonds worth 500 mln yuan

* Says it issued 2017 first tranche corporate bonds worth 500 million yuan with a coupon rate of 5.9 percent

Oct 24 2017

BRIEF-Guizhou Yibai Pharmaceutical sets coupon rate of 2017 1st tranche corporate bonds at 5.9 pct

* Says it sets coupon rate of 2017 1st tranche corporate bonds at 5.9 percent

Oct 23 2017

BRIEF-Guizhou Yibai Pharmaceutical issues 1st tranche of 2017 bonds worth 500 bln yuan

* Says it issues 1st tranche of 2017 bonds worth 500 million yuan ($75.55 million) of maturity of up to 5 years

Oct 17 2017

BRIEF-Guizhou Yibai Pharmaceutical to pay FY 2016 annual div on July 18

July 12 Guizhou Yibai Pharmaceutical Co Ltd : * Says it plans to pay FY 2016 annual div on July 18 Source text in Chinese: https://goo.gl/786avz Further company coverage: (Beijing Headline News)

Jul 12 2017

BRIEF-Guizhou Yibai Pharmaceutical boosts capital to pharma management firm

* Says it acquired 15 percent stake in Liaoyang-based pharma management firm, and boosted capital of 35.8 million yuan to this pharma company

Jun 20 2017

Earnings vs. Estimates